Loading…
Evotec SE is projected to rise to $2.06 by 2027, a +8% move from its current price of $1.91. EVO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $1.85 | $1.91 | $1.97 | +0.06% |
| Aug 3 | $1.83 | $1.91 | $2.00 | +0.12% |
| Aug 4 | $1.82 | $1.91 | $2.02 | +0.18% |
| Aug 5 | $1.80 | $1.91 | $2.03 | +0.24% |
| Aug 6 | $1.79 | $1.92 | $2.05 | +0.30% |
| Aug 7 | $1.78 | $1.92 | $2.06 | +0.36% |
| Aug 8 | $1.77 | $1.92 | $2.08 | +0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.77 | $1.92 | $2.08 | +0.42% |
| Week 2 | $1.72 | $1.93 | $2.15 | +0.83% |
| Week 3 | $1.69 | $1.93 | $2.22 | +1.25% |
| Week 4 | $1.66 | $1.94 | $2.28 | +1.67% |
| Week 5 | $1.63 | $1.95 | $2.33 | +2.09% |
| Week 6 | $1.61 | $1.96 | $2.38 | +2.52% |
| Week 7 | $1.59 | $1.97 | $2.43 | +2.94% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Evotec SE operates as a drug discovery and development company with a global footprint. It runs two segments, Shared R&D and Just Evotec Biologics, and focuses on developing pharmaceutical products across a range of therapeutic areas. It also works in central nervous system and cardiometabolic diseases, as well as animal and women health.
Evotec SE (EVO) is currently priced at $2.01 and has a market cap of $713.93M. It holds a rank of 2794. The near-term price outlook is grounded in a technical and forecast backdrop that places the stock in a cautious position near term, with a path toward higher levels over the coming years.
A major floor 35.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 52.9% above — a clean break opens room to run.
A major ceiling 72.8% above — clearing it would confirm fresh momentum.
Key EVO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EVO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.93 | Sell | $1.93 | Sell |
| MA 10 | $1.95 | Sell | $1.99 | Sell |
| MA 20 | $2.21 | Sell | $2.15 | Sell |
| MA 50 | $2.57 | Sell | $2.45 | Sell |
| MA 100 | $2.68 | Sell | $2.69 | Sell |
| MA 200 | $3.05 | Sell | $3.00 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 26.25 | Buy |
| Stoch RSI (14) | 70.05 | Neutral |
| CCI (20) | -59.55 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -4.98 | Sell |
| Bollinger %B (20,2) | 0.30 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.19 | Sell |
| Awesome (5,34) | -0.49 | Sell |
| Ultimate (7,14,28) | 30.54 | Neutral |
| Momentum (10) | -0.05 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 1.92 | Sell |
| ADX (14) | 35.95 | Sell |
| ATR (14) | 0.05 | Info |
The sentiment around Evotec SE is NEUTRAL. The RSI14 is 20, while the 50-day simple moving average stands at $2.81 and the 200-day simple moving average at $3.16. The price sits at a support level of $2.01 and faces resistance at $2.97.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.91 | $1.91 | $2.55 | 0% | Neutral | |
| $1.63 | $2.06 | $2.77 | +8% | Neutral | |
| $1.78 | $2.32 | $3.24 | +21% | Bullish | |
| $2.02 | $2.71 | $3.91 | +42% | Bullish | |
| $2.28 | $3.12 | $4.63 | +64% | Bullish | |
| $2.30 | $3.23 | $4.89 | +69% | Bullish | |
| $2.10 | $3.00 | $4.64 | +57% | Bullish | |
| $2.26 | $3.28 | $5.18 | +72% | Bullish | |
| $2.35 | $3.48 | $5.58 | +82% | Bullish | |
| $2.57 | $3.86 | $6.29 | +102% | Bullish | |
| $2.90 | $4.70 | $8.17 | +146% | Bullish | |
| $5.85 | $10.84 | $20.76 | +468% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.91 | $1.91 | $2.25 | +0.00% |
| September 2026 | $1.64 | $1.94 | $2.37 | +1.64% |
| October 2026 | $1.69 | $2.02 | $2.49 | +3.84% |
| November 2026 | $1.66 | $2.00 | $2.50 | -0.68% |
| December 2026 | $1.68 | $2.03 | $2.55 | +1.26% |
Click any year to see its month-by-month EVO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Evotec SE's 2026 outlook centres on $1.91, within a $1.91 to $2.55 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, EVO could reach as high as $2.77, with a base case around $2.06 and support toward $1.63 — roughly +8% from $1.91. Price action looks broadly range-bound.
Expect EVO to range from $1.78 to $3.24 through 2028. The $2.32 average target implies a +21% move from current prices. That is up +12% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The EVO price prediction for 2029 points to an average of $2.71 (low $2.02, high $3.91) — a potential gain of +42% on today's $1.91. Momentum favours further upside here.
In 2030, EVO is projected to trade between $2.28 and $4.63, averaging $3.12 — a potential gain of +64% from today's $1.91. That is up +15% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Evotec SE's 2031 outlook centres on $3.23, within a $2.30 to $4.89 range. That is up +3% on the projected 2030 average. That marks a +69% change versus current levels. Momentum favours further upside here.
By 2032, EVO could reach as high as $4.64, with a base case around $3.00 and support toward $2.10 — roughly +57% from $1.91. Buyers look set to stay in control over this stretch.
Expect EVO to range from $2.26 to $5.18 through 2033. The $3.28 average target implies a +72% move from current prices. That is up +9% on the projected 2032 average. Momentum favours further upside here.
The EVO price prediction for 2034 points to an average of $3.48 (low $2.35, high $5.58) — a potential gain of +82% on today's $1.91. Buyers look set to stay in control over this stretch.
In 2035, EVO is projected to trade between $2.57 and $6.29, averaging $3.86 — a potential gain of +102% from today's $1.91. That is up +11% on the projected 2034 average. Momentum favours further upside here.
Evotec SE's 2040 outlook centres on $4.70, within a $2.90 to $8.17 range. That is up +22% on the projected 2035 average. That marks a +146% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, EVO could reach as high as $20.76, with a base case around $10.84 and support toward $5.85 — roughly +468% from $1.91. Momentum favours further upside here.
Investing $1,000 in EVO today (≈ 523.560209 EVO) could be worth
$5,675.46
+$4,675.46 (+468%) by 2050 · US Dollar
Based on the average projected EVO price of $10.84 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EVOwould be worth at today's price.
$1,000 invested in EVO on Jul 31, 2025 (≈ 251.25628 EVO) would be worth
$479.9
-$520.1 (-52.0%) today · 0.48× · US Dollar
Based on a EVO entry price of $3.98 vs. today's $1.91.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.94 | $984.54 | -1.5% |
| 1 month ago | $2.85 | $670.18 | -33.0% |
| 3 months ago | $3.09 | $618.12 | -38.2% |
| 6 months ago | $3.42 | $558.48 | -44.2% |
| 1 year ago | $3.98 | $479.9 | -52.0% |
| All time (5.0y) ago | $20.31 | $94.03 | -90.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EVO forecast.
Our base-case forecast reaches $3.80 around 2035.
Implied market cap at $3.80: $1.35B
The multi-year forecast sketches a bullish tilt beyond 2029, with the 2030 average price at $3.17 and a 57.9% ROI. In 2040 the average price is projected to be $3.93 with a 95.5% ROI, and by 2050 the average price reaches $10.12 with a max of $22.33 and a 403.2% ROI. These figures reflect a long-run upside despite earlier volatility, with the sentiment in later years labeled BULLISH.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $3.17, a minimum of $2.14, and a maximum of $5.10, with a ROI of 57.9% and a BULLISH sentiment.
The forecast outlines rising averages and positive ROIs, with 2029 ROI of 39.2% and 2030 ROI of 57.9%, and a 2050 ROI of 403.2%. These are estimates, not guarantees.
Yes. The forecast maximum in 2030 is $5.10.
The 2050 forecast shows a min of $4.55, an average of $10.12, and a max of $22.33, with an ROI of 403.2% and a BULLISH sentiment.
The current price is $2.01 and the market cap is $713.93M; the rank is 2794.
Evotec SE Community Discussion
0Share your Evotec SE price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.